CytomX Therapeutics, Inc. Income Statement

Income Statement Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 0.89M5.08M7.71M15.04M71.62M59.50M26.90M68.43M37.31M53.16M101.21M138.10M
Gross Profit 0.89M5.08M7.71M15.04M71.62M59.50M26.90M68.43M37.31M53.16M101.21M138.10M
Operating items
Research & Development 10.89M28.30M28.36M54.76M92.28M103.87M131.62M112.94M114.19M111.65M77.68M83.38M
Selling, General & Administrative 4.95M6.54M12.56M19.87M25.61M33.51M36.77M36.03M39.16M42.85M30.02M29.73M
Operating Expenses 15.84M34.84M40.91M74.63M117.88M137.38M168.38M148.97M153.35M154.50M107.70M113.11M
Operating Income -14.96M-29.77M-33.20M-59.59M-46.26M-77.87M-141.48M-80.54M-116.04M-101.33M-6.48M25.00M
EBIT -14.96M-29.77M-33.20M-59.59M-46.26M-77.87M-141.48M-80.54M-116.04M-101.33M-6.48M25.00M
Non-operating items
Interest & Investment Income 0.01M0.01M1.31M0.74M2.67M7.64M8.37M1.84M0.26M1.68M9.84M7.14M
Other Non Operating Income 0.07M-0.06M-1.74M-0.07M-0.03M-0.07M-0.14M-0.03M-0.08M0.34M-0.03M-0.04M
Non Operating Income 0.07M-0.06M-1.74M-0.07M-0.03M-0.07M-0.14M-0.03M-0.08M0.34M-0.03M-0.04M
Net income details
EBT -15.13M-30.30M-35.36M-58.92M-43.61M-70.30M-133.25M-78.73M-115.87M-99.32M3.32M32.09M
Tax Provisions 0.01M0.01M0.01M-0.02M-0.51M14.30M-0.43M-13.91M3.89M0.22M
Profit After Tax -15.14M-30.31M-35.37M-58.90M-43.10M-84.60M-132.82M-64.82M-115.87M-99.32M-0.57M31.87M
Income from Continuing Operations -15.14M-30.31M-35.37M-58.90M-43.10M-84.60M-132.82M-64.82M-115.87M-99.32M-0.57M31.87M
Consolidated Net Income -15.14M-30.31M-35.37M-58.90M-43.10M-84.60M-132.82M-64.82M-115.87M-99.32M-0.57M31.87M
Income towards Parent Company -15.14M-30.31M-35.37M-58.90M-43.10M-84.60M-132.82M-64.82M-115.87M-99.32M-0.57M31.87M
Preferred Dividend Payments 3.75M4.57M6.71M
Net Income towards Common Stockholders -18.89M-34.88M-42.08M-58.90M-43.10M-84.60M-132.82M-64.82M-115.87M-99.32M-0.57M31.87M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M-0.00M0.00M
Shares Outstanding (Weighted Average) 36.02M36.40M38.41M45.01M45.43M46.22M65.25M66.08M66.99M78.26M
Shares Outstanding (Diluted Average) 45.34M46.60M65.30M65.74M73.81M
EBITDA -15.14M-30.31M-35.45M-58.85M-43.17M-84.60M-132.68M-64.92M-116.06M-99.06M-0.48M31.80M
Tax Rate 0.03%1.18%0.32%17.67%0.70%